☰

Aparna H. Kesarwala, Ph.D. - Publications

Affiliations: 
2008 Washington University, Saint Louis, St. Louis, MO 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Kambach DM, Halim AS, Cauer AG, Sun Q, Tristan CA, Kesarwala AH, Shankavaram U, Batchelor E, Stommel JM. Abstract B097: Dysregulated mevalonate and cholesterol synthesis is a therapeutic vulnerability in glioblastoma Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-B097  0.332
2017 Kesarwala AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, Cengel KA, Evans TL, Aggarwal C, Cohen RB, Langer CJ, Rengan R, Simone CB. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer. Clinical Lung Cancer. PMID 29153967 DOI: 10.1016/J.Cllc.2017.10.001  0.344
2017 Kambach DM, Halim AS, Cauer AG, Sun Q, Tristan CA, Celiku O, Kesarwala AH, Shankavaram U, Batchelor E, Stommel JM. Disabled cell density sensing leads to dysregulated cholesterol synthesis in glioblastoma. Oncotarget. PMID 28118603 DOI: 10.18632/Oncotarget.14740  0.32
2017 Kesarwala A, Kim C, Jones J, Kaushal A, Roper N, Hoang C, Szabo E, Connolly M, Padiernos E, Cultraro C, Waris M, Gao S, Steinberg S, Khan J, Rajan A, et al. Radiation As a Local Ablative Therapy Option for Oligoprogressive EGFR-Mutant Non-Small Cell Lung Cancer after Treatment with Osimertinib International Journal of Radiation Oncology*Biology*Physics. 99: E467-E468. DOI: 10.1016/J.Ijrobp.2017.06.1719  0.311
2016 Kim C, Hoang CD, Kesarwala AH, Schrump DS, Guha U, Rajan A. Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non-Small-Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 27780780 DOI: 10.1016/J.Jtho.2016.10.012  0.336
2016 Basudhar D, Ridnour LA, Cheng R, Kesarwala AH, Heinecke J, Wink DA. Biological signaling by small inorganic molecules. Coordination Chemistry Reviews. 306: 708-723. PMID 26688591 DOI: 10.1016/J.Ccr.2015.06.001  0.346
2014 Kesarwala A, Krishna M, Mitchell J. Oxidative stress in oral diseases. Oral Diseases. PMID 25417961 DOI: 10.1111/Odi.12300  0.302
2014 Cheng RY, Basudhar D, Ridnour LA, Heinecke JL, Kesarwala AH, Glynn S, Switzer CH, Ambs S, Miranda KM, Wink DA. Gene expression profiles of NO- and HNO-donor treated breast cancer cells: insights into tumor response and resistance pathways. Nitric Oxide : Biology and Chemistry / Official Journal of the Nitric Oxide Society. 43: 17-28. PMID 25153034 DOI: 10.1016/J.Niox.2014.08.003  0.315
2013 Kesarwala AH, Grover S, Rengan R. Role of particle beam therapy in a trimodality approach to locally advanced non-small cell lung cancer. Thoracic Cancer. 4: 95-101. PMID 28920191 DOI: 10.1111/J.1759-7714.2012.00174.X  0.316
2012 Kesarwala AH, Lu DJ, Xanthopoulos E, Apisarnthanarax S, Evans T, Aggarwal C, Cohen RB, Langer CJ, Rengan R, Simone CB. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Prior to Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1550  0.344
2012 Kesarwala A, Ko C, O'Meara W, Ning H, Haglund K, Xanthopoulos E, Rengan R. Feasibility of Proton Therapy for Elective Nodal Irradiation in Patients With Locally Advanced Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S577-S578. DOI: 10.1016/J.Ijrobp.2012.07.1540  0.312
2009 Dothager RS, Flentie K, Moss B, Pan MH, Kesarwala A, Piwnica-Worms D. Advances in bioluminescence imaging of live animal models. Current Opinion in Biotechnology. 20: 45-53. PMID 19233638 DOI: 10.1016/J.Copbio.2009.01.007  0.577
2009 Kesarwala AH, Samrakandi MM, Piwnica-Worms D. Proteasome inhibition blocks ligand-induced dynamic processing and internalization of epidermal growth factor receptor via altered receptor ubiquitination and phosphorylation. Cancer Research. 69: 976-83. PMID 19176375 DOI: 10.1158/0008-5472.Can-08-2938  0.523
2007 Bullok KE, Maxwell D, Kesarwala AH, Gammon S, Prior JL, Snow M, Stanley S, Piwnica-Worms D. Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. Biochemistry. 46: 4055-65. PMID 17348687 DOI: 10.1021/Bi061959N  0.609
2006 Kesarwala AH, Prior JL, Sun J, Harpstrite SE, Sharma V, Piwnica-Worms D. Second-generation triple reporter for bioluminescence, micro-positron emission tomography, and fluorescence imaging. Molecular Imaging. 5: 465-74. PMID 17150159 DOI: 10.2310/7290.2006.00024  0.529
2006 Piwnica-Worms D, Kesarwala AH, Pichler A, Prior JL, Sharma V. Single photon emission computed tomography and positron emission tomography imaging of multi-drug resistant P-glycoprotein--monitoring a transport activity important in cancer, blood-brain barrier function and Alzheimer's disease. Neuroimaging Clinics of North America. 16: 575-89, viii. PMID 17148020 DOI: 10.1016/J.Nic.2006.06.007  0.496
Show low-probability matches.